RECRUITINGOBSERVATIONAL
Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia
BASEL VIII Trial - Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia
About This Trial
The primary aim is to perform the largest study worldwide to evaluate novel biochemical and electrocardiographic signatures alone as well as in combination with the standard 12-lead exercise ECG in the detection of exercise-induced myocardial ischemia (diagnostic endpoint). The secondary aim is to evaluate these innovative tools in the risk prediction for the occurrence of cardiovascular death and acute myocardial infarction during long-term follow-up.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients presenting with suspected exercise-induced myocardial ischemia referred for rest/ergometry myocardial perfusion SPECT
Who Should NOT Join This Trial:
- Age \< 18 years
- Pregnancy
- Unable or unwilling to give willing to sign a consent form
- Symptoms at rest or minor exertion
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients presenting with suspected exercise-induced myocardial ischemia referred for rest/ergometry myocardial perfusion SPECT
Exclusion Criteria:
* Age \< 18 years
* Pregnancy
* Unable or unwilling to give informed consent
* Symptoms at rest or minor exertion
Locations (1)
University Hospital Basel
Basel, Switzerland